P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,774.60
-71.8 (-1.23%)
BSENSE

Dec 05

BSE+NSE Vol: 2.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
520.24
143.42
27.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
520.24
143.42
27.57%
Raw Material Cost
137.67
216.31
-78.64
-36.36%
Purchase of Finished goods
34.95
0.00
34.95
(Increase) / Decrease In Stocks
-10.23
24.45
-34.68
-141.84%
Employee Cost
109.89
35.98
73.91
205.42%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
67.56
113.21
167.57%
Total Expenditure (Excl Depreciation)
453.05
344.30
108.75
31.59%
Operating Profit (PBDIT) excl Other Income
210.61
175.94
34.67
19.71%
Other Income
8.98
32.53
-23.55
-72.39%
Operating Profit (PBDIT)
219.59
208.47
11.12
5.33%
Interest
0.24
5.32
-5.08
-95.49%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
203.15
16.20
7.97%
Depreciation
11.52
11.56
-0.04
-0.35%
Profit Before Tax
207.83
191.59
16.24
8.48%
Tax
53.11
48.28
4.83
10.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
143.31
11.41
7.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
143.31
11.41
7.96%
Equity Capital
16.60
34.69
-18.09
-52.15%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
8.26
84.94
1,028.33%
Diluted Earnings per share
93.21
8.26
84.95
1,028.45%
Operating Profit Margin (Excl OI)
31.73%
33.82%
0.00
-2.09%
Gross Profit Margin
33.05%
39.05%
0.00
-6.00%
PAT Margin
23.31%
27.55%
0.00
-4.24%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024